Search
Enter keywords, a title or a report id number below.
Central Nervous System
-
- -
- - You are in Central Nervous System category
- - You are in Central Nervous System category
- -
In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.
Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia,
... more
Sort by
Sorted by
Date Published
-
Acute Pain - Pipeline Review, H1 2013
Global Markets Direct, Feb 2013 , Pages: 186Acute Pain – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Acute Pain - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides... -
Insomnia - Pipeline Review, H1 2013
Global Markets Direct, Feb 2013 , Pages: 87Insomnia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Insomnia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information... -
Spinal Cord Injury - Pipeline Review, H1 2013
Global Markets Direct, Feb 2013 , Pages: 199Spinal Cord Injury – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Spinal Cord Injury - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This... -
Fibromyalgia - Pipeline Review, H1 2013
Global Markets Direct, Feb 2013 , Pages: 81Global Markets Direct's, 'Fibromyalgia - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for... -
Encephalitis - Pipeline Review, H1 2013
Global Markets Direct, Feb 2013 , Pages: 102Encephalitis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Encephalitis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides... -
Spasticity - Pipeline Review, H1 2013
Global Markets Direct, Feb 2013 , Pages: 79Spasticity – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Spasticity - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides... -
Osteoarthritis Pain - Pipeline Review, H1 2013
Global Markets Direct, Feb 2013 , Pages: 127Osteoarthritis Pain – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Osteoarthritis Pain - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This... -
Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2013
Global Markets Direct, Feb 2013 , Pages: 274Amyotrophic Lateral Sclerosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Amyotrophic Lateral Sclerosis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic... -
Inflammatory Pain - Pipeline Review, H1 2013
Global Markets Direct, Feb 2013 , Pages: 127Inflammatory Pain – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Inflammatory Pain - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report... -
Cognitive Impairment - Pipeline Review, H1 2013
Global Markets Direct, Feb 2013 , Pages: 186Cognitive Impairment – Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Cognitive Impairment - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This... -
Mental Health and Work: Denmark
OECD Publishing, Feb 2013 , Pages: 128Tackling mental ill-health of the working-age population is becoming a key issue for labour market and social policies in OECD countries OECD governments increasingly recognise that policy has a major... -
Brain Monitoring Market [By Product [EEG/Magnetoencephalography (MEG)/ Intracranial Pressure Monitor/Cerebral Oximeter/ Transcranial Doppler] & Application [Sleep Disorders/ Epilepsy/Traumatic Brain Injury/Brain Death] – Global Forecasts to 2017
Markets and Markets, Feb 2013 , Pages: 313The global brain monitoring devices market was valued at $1 08 billion in 2012, and is poised to grow at a CAGR of 8 6% to reach $1 63 billion by 2017 The market offers a variety of brain monitoring... -
Child Abuse Global Clinical Trials Review, H1, 2013
GlobalData, Jan 2013 , Pages: 59This clinical trial report, Child Abuse Global Clinical Trials Review, H1, 2013 provides data on the Child Abuse clinical trial scenario The report provides elemental information and data relating to... -
Mental Health and Work: Belgium
OECD Publishing, Jan 2013 , Pages: 120Tackling mental ill-health of the working-age population is becoming a key issue for labour market and social policies in OECD countries OECD governments increasingly recognise that policy has a major... -
Research Report on China’s Anti-Alzheimer’s Disease (AD) Drug Market, 2013-2017
China Research & Intelligence, Jan 2013 , Pages: 40By the end of 2011, people aged 60 and above reached 185 million in China, accounting for 13 7% of the population, with an increase of 0 47 percentage point compared with that at the end of 2010 The... -
Friedreich Ataxia Global Clinical Trials Review, H1, 2013
GlobalData, Jan 2013 , Pages: 87Friedreich Ataxia Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Friedreich Ataxia Global Clinical Trials Review, H1, 2013" provides data on the Friedreich Ataxia clinical... -
Global Markets for Neurosurgical Products
Life Science Intelligence, Dec 2012 , Pages: 204Common conditions necessitating the use of neurosurgical products include hydrocephalus, aneurysms, arteriovenous malformations (AVMs), and pituitary and intracranial tumors Intracranial shunts are... -
Anxiety Disorders - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 155Anxiety Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Anxiety Disorders - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report... -
Brain Injury - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 42Brain Injury – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Brain Injury - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides... -
Cerebral Infarction (Brain Infarction) - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 33Cerebral Infarction (Brain Infarction) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Cerebral Infarction (Brain Infarction) - Pipeline Review, H2 2012', provides an overview of the... -
Diabetic Neuropathic Pain - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 85Diabetic Neuropathic Pain – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Diabetic Neuropathic Pain - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline.... -
Cancer Anorexia - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 22Cancer Anorexia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Cancer Anorexia - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report... -
Mania - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 49Mania – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Mania - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information... -
Nicotine Addiction - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 74Nicotine Addiction – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Nicotine Addiction - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This... -
Demyelinating Diseases - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 87Demyelinating Diseases – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Demyelinating Diseases - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline.... -
General Anxiety Disorder - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 44General Anxiety Disorder – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'General Anxiety Disorder - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline.... -
Japanese Encephalitis - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 57Japanese Encephalitis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Japanese Encephalitis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline.... -
Degenerative Disc Disease - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 34Degenerative Disc Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Degenerative Disc Disease - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline.... -
Neurology - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 526Neurology – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Neurology - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information... -
Dementia - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 136Dementia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Dementia - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information... -
Seizures - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 59Seizures – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Seizures - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information... -
Post-Operative Pain - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 210Post-Operative Pain – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Post-Operative Pain - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This... -
Other Neurologic Disorders - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 45Other Neurologic Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Other Neurologic Disorders - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic... -
Addiction - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 362Addiction – Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Addiction - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline This report provides information... -
Cognitive Disorders - Pipeline Review, H2 2012
Global Markets Direct, Dec 2012 , Pages: 286Cognitive Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Cognitive Disorders - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This... -
Brain Ischemia - Pipeline Review, H2 2012
Global Markets Direct, Nov 2012 , Pages: 44Brain Ischemia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Brain Ischemia - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides... -
Generalized Seizures - Pipeline Review, H2 2012
Global Markets Direct, Nov 2012 , Pages: 51Generalized Seizures – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Generalized Seizures - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This... -
Obsessive-Compulsive Disorder - Pipeline Review, H2 2012
Global Markets Direct, Nov 2012 , Pages: 59Obsessive-Compulsive Disorder – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Obsessive-Compulsive Disorder - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic... -
Spinal Stenosis - Pipeline Review, H2 2012
Global Markets Direct, Nov 2012 , Pages: 32Spinal Stenosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Spinal Stenosis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report... -
Ataxia - Pipeline Review, H2 2012
Global Markets Direct, Nov 2012 , Pages: 36Ataxia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Ataxia - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information... -
Moderate Pain - Pipeline Review, H2 2012
Global Markets Direct, Nov 2012 , Pages: 45Moderate Pain – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Moderate Pain - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides... -
Delirium - Pipeline Review, H2 2012
Global Markets Direct, Nov 2012 , Pages: 32Delirium – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Delirium - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information... -
Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2012
Global Markets Direct, Nov 2012 , Pages: 46Secondary Progressive Multiple Sclerosis (SPMS) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2012', provides an... -
Dental Pain - Pipeline Review, H2 2012
Global Markets Direct, Nov 2012 , Pages: 50Dental Pain – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Dental Pain - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides... -
Low Back Pain - Pipeline Review, H2 2012
Global Markets Direct, Nov 2012 , Pages: 73Low Back Pain – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Low Back Pain - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides... -
Neuralgia - Pipeline Review, H2 2012
Global Markets Direct, Nov 2012 , Pages: 147Neuralgia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Neuralgia - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information... -
Eating (Appetite) Disorders - Pipeline Review, H2 2012
Global Markets Direct, Nov 2012 , Pages: 37Eating (Appetite) Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Eating (Appetite) Disorders - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic... -
Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2012
Global Markets Direct, Nov 2012 , Pages: 45Cognitive Impairment Associated With Schizophrenia (CIAS) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review,... -
Pain - Pipeline Review, H2 2012
Global Markets Direct, Nov 2012 , Pages: 294Pain – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Pain - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information... -
Stem Cell Approaches in Neurology and Psychiatry: 25 Trend Setters for 2013 - 3rd Biennial Report
NeuroInsights, Nov 2012 , Pages: 200An Industry Insider Report on Innovative Research and Development in Stem Cell Technology for the Central Nervous System Stem cell approaches in neurology and psychiatry is the focus of a new report...
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
